| Cvs Pharmacy #06811 | |
| 4140 County Road 101 N, Minneapolis, Minnesota 55446 | |
| (763) 478-4612 |
| Name | Cvs Pharmacy #06811 |
|---|---|
| Organization Name | Grand St Paul Cvs Llc |
| Location | 4140 County Road 101 N, Minneapolis, Minnesota 55446 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (763) 478-4612 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cardiovascular and metabolic disease, today announced additional data from its ongoing Phase III trial involving its lead cholesterol management compound, lomitapide (AEGR-733), which is a microsomal triglyceride transfer protein (MTP) inhibitor small molecule drug.
InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA (miRNA)-based therapeutics for cancer, today announced that it was awarded an Innovation Credit of EUR 1.3 million from the Dutch government.
Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients.
Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.
› Verified 9 days ago
| NPI Number | 1952401390 |
| Organization Name | GRAND ST PAUL CVS LLC |
| Doing Business As | CVS PHARMACY #06811 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4140 Rd 101 N, Plymouth, MN 55446 |
| Phone Number | 763-478-4612 |
News Archive
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cardiovascular and metabolic disease, today announced additional data from its ongoing Phase III trial involving its lead cholesterol management compound, lomitapide (AEGR-733), which is a microsomal triglyceride transfer protein (MTP) inhibitor small molecule drug.
InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA (miRNA)-based therapeutics for cancer, today announced that it was awarded an Innovation Credit of EUR 1.3 million from the Dutch government.
Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients.
Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.
› Verified 9 days ago
News Archive
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cardiovascular and metabolic disease, today announced additional data from its ongoing Phase III trial involving its lead cholesterol management compound, lomitapide (AEGR-733), which is a microsomal triglyceride transfer protein (MTP) inhibitor small molecule drug.
InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA (miRNA)-based therapeutics for cancer, today announced that it was awarded an Innovation Credit of EUR 1.3 million from the Dutch government.
Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients.
Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.
› Verified 9 days ago
Mesa Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2603 Bloomington Ave, Minneapolis, Minnesota 55407 Phone: (612) 501-5009 | |
Alina Health System Type: Community/Retail Pharmacy Location: 913 E 28th Street, Minneapolis, Minnesota 55407 Phone: (612) 863-5370 | |
Allina Health System Type: Clinic Pharmacy Location: 920 E 28th St, Minneapolis, Minnesota 55407 Phone: (612) 775-3100 | |
Cvs Pharmacy #07172 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2001 Nicollet Ave, Minneapolis, Minnesota 55404 Phone: (612) 872-2656 | |
Cvs Pharmacy #05996 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3655 Central Ave Ne, Minneapolis, Minnesota 55418 Phone: (612) 789-2460 |